Activity value 75china Supplier,Last transaction date:
2026-06-26
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for xiwang pharmaceuticals co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 24 transactions, with a transaction quantity of 1822788 and a transaction weight of 1833913.01.
YearTransactionsQuantityWeight
20252014480001893280
20262418227881833913.01
Bill of lading data
<
1/15
>
Trade date
2026/06/26
B/L No.
721502067
Suppliers
xiwang pharmaceuticals co.ltd.
Buyers
neco philippines inc.
POLs
——
PODs
manila international container terminal
xiwang pharmaceuticals co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as dextrose anhydrous,bags,bag.
According to the 52wmb.com global trade database, as of 2026-06-26, the company has completed 389 international trades,
with its main trading regions covering philippines,vietnam,pakistan etc.
The core products include HS17023010000,HS17023010 etc,
often transported via qingdao,port jebel ali, port manila etc,
and its main trading partners are công ty tnhh kiến vương,renata ltd. change from pfizer,sam lim corp./w.l. food products.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on xiwang pharmaceuticals co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.